Nubeqa plus ADT improved rPFS in mHSPC regardless of disease volume, reducing the risk of radiological progression or death ...

Results from the PEACOCC trial warrant further investigation into treatment with pembrolizumab in patients with previously ...

The publication reviews the results of 204 patients with 12 tumor types enrolled and treated on the eNRGy study, concluding “Zenocutuzumab demonstrated durable efficacy in patients with advanced NRG1+ ...

Beyond improving accuracy, xAI allowed researchers to compare prognostic markers across different cancer types, unveiling ...

Frontline treatment with Tevimbra plus irinotecan, paclitaxel, oxaliplatin and 5-FU/leucovorin had promising efficacy and ...

T-DM1 was tolerable in HER2-positive biliary tract adenocarcinoma but did not significantly improve progression-free survival ...

Members of the media are hereby invited to a media briefing where the Minister of Electricity and Energy, Dr Kgosientsho Ramokgopa and Eskom will provide an update on the status of South Africa’s ...

The U.S. stock market displayed mixed performance following the Federal Reserve's decision to hold interest rates steady following the release of key economic data. The Dow Jones Industrial ...

Lung cancer is one of the most common types of cancer in the United States and a leading cause of cancer deaths. However, the timeline of how the disease progresses can vary based on several factors.

At the same time, someone who is healthy and has a strong performance status (meaning the ability to care for themselves) is more likely to withstand aggressive cancer treatments than someone who is ...

The Web Script /service/components/article/2010/03/how-individual-performance-sca has responded with a status of 500 - Internal Error. 500 Description: An error ...

ECOG performance status, histological subtype, and the number of treatment lines were also found ... or financial relationships that could be construed as a potential conflict of interest. NSCLC, ...